Graphene-Based Materials Prove to Be a Promising Candidate for Nerve Regeneration Following Peripheral Nerve Injury
- PMID: 35052753
- PMCID: PMC8773001
- DOI: 10.3390/biomedicines10010073
Graphene-Based Materials Prove to Be a Promising Candidate for Nerve Regeneration Following Peripheral Nerve Injury
Erratum in
-
Correction: Aleemardani et al. Graphene-Based Materials Prove to Be a Promising Candidate for Nerve Regeneration Following Peripheral Nerve Injury. Biomedicines 2022, 10, 73.Biomedicines. 2025 Jul 14;13(7):1711. doi: 10.3390/biomedicines13071711. Biomedicines. 2025. PMID: 40722861 Free PMC article.
Abstract
Peripheral nerve injury is a common medical condition that has a great impact on patient quality of life. Currently, surgical management is considered to be a gold standard first-line treatment; however, is often not successful and requires further surgical procedures. Commercially available FDA- and CE-approved decellularized nerve conduits offer considerable benefits to patients suffering from a completely transected nerve but they fail to support neural regeneration in gaps > 30 mm. To address this unmet clinical need, current research is focused on biomaterial-based therapies to regenerate dysfunctional neural tissues, specifically damaged peripheral nerve, and spinal cord. Recently, attention has been paid to the capability of graphene-based materials (GBMs) to develop bifunctional scaffolds for promoting nerve regeneration, often via supporting enhanced neural differentiation. The unique features of GBMs have been applied to fabricate an electroactive conductive surface in order to direct stem cells and improve neural proliferation and differentiation. The use of GBMs for nerve tissue engineering (NTE) is considered an emerging technology bringing hope to peripheral nerve injury repair, with some products already in preclinical stages. This review assesses the last six years of research in the field of GBMs application in NTE, focusing on the fabrication and effects of GBMs for neurogenesis in various scaffold forms, including electrospun fibres, films, hydrogels, foams, 3D printing, and bioprinting.
Keywords: biomedicine; drug delivery; functionalized graphene oxide; graphene-based materials; nerve differentiation; nerve proliferation; nerve tissue engineering; nervous system; plastic surgery; regenerative medicine; spinal cord injury; surgery.
Conflict of interest statement
Alexander M. Seifalian is the co-founder and scientific director of NanoRegMed Ltd., as indicated in the affiliation. He and his research team have developed and patented a graphene-based nanocomposite material; trade registered as BioHastalex®. This has been highlighted in the manuscript as their current work in London. Amelia Seifalian is associated with NanoRegMed but does not hold a formal position or receive financial compensation from the company.
Figures
References
-
- Ahadian S., Obregón R., Ramón-Azcón J., Salazar G., Shiku H., Ramalingam M., Matsue T. Carbon nanotubes and graphene-based nanomaterials for stem cell differentiation and tissue regeneration. J. Nanosci. Nanotechnol. 2016;16:8862–8880. doi: 10.1166/jnn.2016.12729. - DOI
-
- Aydin T., Gurcan C., Taheri H., Yilmazer A. Graphene based materials in neural tissue regeneration. Adv. Exp. Med. Biol. 2018;1107:129–142. - PubMed
-
- Reddy S., Xu X., Guo T., Zhu R., He L., Ramakrishana S. Allotropic carbon (graphene oxide and reduced graphene oxide) based biomaterials for neural regeneration. Curr. Opin. Biomed. Eng. 2018;6:120–129. doi: 10.1016/j.cobme.2018.05.001. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
